Market Data & News for RGEN
RGEN News from SmallCapInvestor.com
Orexigen Therapeutics, Repligen and Affymetrix lead small-cap volume in pre-market
Repligen to repurchase up to 1.25M shares
Pre-market: Pomeroy IT Solutions, Origin Agritech and Repligen lead small-cap volume
Repligen surges after settling patent suit with Bristol-Myers
Russell 2000 futures lower
Repligen Corp.: All you need is cash
Pre-market: Vical Inc. receives $6 million grant
